BIVV001

· Bioverativ, a Sanofi company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIVV001, covering 2024-02-13 to 2024-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A [Phase 3]